The International Symposium on the Separation of Proteins, Peptides and Polynucleotides ISPPP 2016 is the 36th meeting in the ISPPP series. The symposium invites researchers, engineers and technicians from bio-pharmaceutical and supply industries, research institutions and universities to share insights in separation technologies and related fields. The 2016 event will take place in Salzburg, Austria, from November 6th to 9th.
This year's edition of the well-established ISPPP (International Symposium on the Separation of Proteins, Peptides and Polynucleotides) conference series gives the possibility to present and discuss the latest results in the field of separation of biomolecules. Additionally, ISPPP is a place for networking with renowned scientists in the field but also with young researchers making their first steps in the scientific community.
The ISPPP 2016 will cover topics as HCP analysis, biosimilars, 2- & 3-dimensional analytics, HPLC-MS technologies, scale-up and scale-down of chromatography, virus and VLP isolation, DNA separation, protein standards and standardization, biopharmaceuticals, protein nutraceuticals, high molecular weight species and superstructures. Furthermore, there will be an exhibition area showcasing the latest separation technologies.
Early registration for the symposium held from November 6th to 9th in Salzburg, Austria, with discount rates from 300 to 950 Euro will be possible until July 15th. Find all information at http://www.
The ISPPP 2016 is organized by acib, the Austrian Centre of Industrial Biotechnology. Find additional information about the ISPPP series at http://www.
The Austrian Centre of Industrial Biotechnology (acib) is an international research center for industrial biotech-nology with locations in Vienna, Graz, Innsbruck, Tulln, Hamburg and Bielefeld (D), Pavia (I), Barcelona (E) and Rzeszow (P). acib sees itself as a scientific and industrial network of 130+ partners, including 3M, Biomin, Boehringer Ingelheim RCV, DSM, DPx, Lonza, Sandoz or VTU Technology.
At acib, 200+ employees work on more than 70 research projects with the final goal to replace conventional industrial processes and products by more environmentally friendly and more economical approaches. More information about acib's research can be fount in our "Biotech Stories": goo.gl/3GBEr9
acib is owned by the University of Natural Resources and Life Sciences, Graz University of Technology, the Universities of Innsbruck and Graz and the Styrian Joanneum Research. acib is financed by industrial and public contributions. The latter come from the Austrian Research Promotion Agency of the Republic of Austria (FFG), Standortagentur Tirol, Styrian Business Promotion Agency (SFG), the province of Lower Austria and the Vienna Business Agency.